14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.25 $5.08 Wednesday, 1st May 2024 AVXL stock ended at $3.69. This is 1.10% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 9.07% from a day low at $3.53 to a day high of $3.85.
90 days $3.25 $6.15
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Dec 07, 2022 $8.34 $9.10 $8.31 $8.49 2 737 453
Dec 06, 2022 $9.21 $9.21 $8.34 $8.38 6 006 781
Dec 05, 2022 $12.03 $12.11 $9.56 $9.58 8 403 482
Dec 02, 2022 $12.57 $13.23 $10.66 $12.05 45 682 568
Dec 01, 2022 $8.90 $9.57 $8.80 $8.87 2 157 524
Nov 30, 2022 $8.96 $9.14 $8.29 $8.82 4 017 257
Nov 29, 2022 $9.24 $9.46 $8.77 $8.94 2 155 419
Nov 28, 2022 $12.46 $12.49 $8.87 $9.10 4 351 921
Nov 25, 2022 $11.30 $11.95 $11.25 $11.89 778 695
Nov 23, 2022 $11.72 $11.86 $11.09 $11.36 958 169
Nov 22, 2022 $11.80 $11.80 $10.97 $11.42 1 052 751
Nov 21, 2022 $12.68 $12.73 $11.37 $11.38 1 013 898
Nov 18, 2022 $13.22 $13.25 $12.64 $12.71 579 317
Nov 17, 2022 $13.59 $13.78 $12.41 $12.48 1 114 253
Nov 16, 2022 $14.22 $14.55 $13.61 $13.63 613 739
Nov 15, 2022 $14.51 $14.67 $13.97 $14.26 711 362
Nov 14, 2022 $14.60 $15.24 $14.25 $14.33 1 223 991
Nov 11, 2022 $13.50 $14.73 $13.50 $14.32 1 106 424
Nov 10, 2022 $12.30 $13.55 $12.27 $13.42 1 265 818
Nov 09, 2022 $12.00 $12.29 $11.75 $11.82 564 387
Nov 08, 2022 $11.55 $12.48 $11.49 $12.17 873 718
Nov 07, 2022 $11.86 $11.99 $11.42 $11.49 675 619
Nov 04, 2022 $11.85 $11.85 $11.13 $11.73 794 750
Nov 03, 2022 $11.66 $12.01 $11.54 $11.72 514 545
Nov 02, 2022 $12.40 $12.74 $11.76 $11.78 770 620
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT